131 related articles for article (PubMed ID: 7700074)
1. Efficacy and tolerability of cilazapril in patients with essential hypertension.
Karpov YA; Vilchinskaya MY; Sorokin EV; Podinovskaya VA
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S86-8. PubMed ID: 7700074
[TBL] [Abstract][Full Text] [Related]
2. Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study.
Leonetti G; Salvetti A
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S73-7. PubMed ID: 7700071
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of 5 mg of cilazapril plus 12.5 mg of hydrochlorothiazide in mild-to-moderate hypertension: results of 24-hour ambulatory blood pressure monitoring.
Martina B; Weinbacher M; Gasser P; Rhyner K; Köhler M; Wohler D; LeBloch Y; Bart T
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S89-92. PubMed ID: 7700075
[TBL] [Abstract][Full Text] [Related]
4. Review of studies on the clinical pharmacodynamics of cilazapril.
Belz GG; Breithaupt K; Erb K
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S14-9. PubMed ID: 7898090
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile.
Prager G; Klein P; Schmitt M; Prager R
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S93-9. PubMed ID: 7700076
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the efficacy and tolerance of the new delayed-action angiotensin-converting enzyme inhibitor cilazapril in patients with hypertension (preliminary report)].
Vil'chinskaia MIu; Sorokin EV; Podinovskaia IaV; Karpov IuA
Ter Arkh; 1993; 65(9):32-4. PubMed ID: 8303591
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effect of cilazapril in essential hypertensive patients. Clinical study with 24 h ambulatory blood pressure monitoring.
Hiwatari M; Abe K; Yoshinaga K; Saito T
Arzneimittelforschung; 1991 Nov; 41(11):1137-40. PubMed ID: 1839765
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
[TBL] [Abstract][Full Text] [Related]
11. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
[TBL] [Abstract][Full Text] [Related]
13. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the effects of the angiotensin converting enzyme inhibitor cilazapril on diurnal blood pressure.
Nakanishi T; Takahashi H; Nishimura M; Yoshimura M
Clin Ther; 1993; 15(2):294-303. PubMed ID: 8519038
[TBL] [Abstract][Full Text] [Related]
15. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
Fernandez PG; Bolli P; Lee C
Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
[TBL] [Abstract][Full Text] [Related]
16. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
17. Discrepancies between clinic and ambulatory blood pressure responses to cilazapril therapy.
Lacourcière Y; Leenen F; Rangno R; Spence JD; Lenis JH; Myers MG
Can J Cardiol; 1994; 10(6):605-10. PubMed ID: 8044721
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cilazapril and nifedipine retard on ambulatory blood pressure, metabolic, rheological and platelet function in hypertensive patients.
Ding YA; Law HW; Chou TC
J Hum Hypertens; 1994 Feb; 8(2):137-43. PubMed ID: 8207740
[TBL] [Abstract][Full Text] [Related]
20. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
